Feasibility of Near-infrared Photoimmunotherapy Combined With Immune Checkpoint Inhibitor Therapy in Unresectable Head and Neck Cancer
Anticancer Research · 2024
DOI: 10.21873/anticanres.17218 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Hitoshi Hirakawa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan aoi23@med.u-ryukyu.a…. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Head and Neck Neoplasms, Immunotherapy, Feasibility Studies. Die Arbeit wurde bisher 16-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan aoi23@med.u-ryukyu.ac.jp.
- Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
Zitieren
APA
Hirakawa, H., Ikegami, T., Kinjyo, H., Hayashi, Y., Agena, S., Higa, T., Kondo, S., Toyama, M., Maeda, H., & Suzuki, M. (2024). Feasibility of Near-infrared Photoimmunotherapy Combined With Immune Checkpoint Inhibitor Therapy in Unresectable Head and Neck Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.17218
Vancouver
Hirakawa H, Ikegami T, Kinjyo H, Hayashi Y, Agena S, Higa T, et al. Feasibility of Near-infrared Photoimmunotherapy Combined With Immune Checkpoint Inhibitor Therapy in Unresectable Head and Neck Cancer. Anticancer Research. 2024. doi:10.21873/anticanres.17218
BibTeX
@article{Hirakawa2024,
author = {Hirakawa, Hitoshi and Ikegami, Taro and Kinjyo, Hidetoshi and Hayashi, Yoshikazu and Agena, Shinya and Higa, Teruyuki and Kondo, Shunsuke and Toyama, Masatomo and Maeda, Hiroyuki and Suzuki, Mikio},
title = {Feasibility of Near-infrared Photoimmunotherapy Combined With Immune Checkpoint Inhibitor Therapy in Unresectable Head and Neck Cancer},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.17218}
}
EUVIMED